Historical Stock Price
ETFs Holding CDMO »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
03/17/2023 $17.97 $18.31 $17.68 $17.80 2.87M
03/20/2023 $18.09 $18.42 $17.81 $17.95 559.50K
03/21/2023 $18.20 $18.38 $17.95 $18.00 502.20K
03/22/2023 $17.88 $18.05 $17.33 $17.38 601.00K
03/23/2023 $17.39 $17.92 $17.18 $17.53 509.90K
Avid Bioservices is a contract development and manufacturing organization that provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing, focused on biopharmaceutical drug substances derived from mammalian cell culture. Co. produces monoclonal antibodies and recombinant proteins, and its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. Co. also provides process development services, including upstream and downstream development, analytical method development, testing and characterization.
CDMO historical stock prices picture
Avid Bioservices (CDMO) has the following price history information. Looking back at CDMO historical stock prices for the last five trading days, on March 17, 2023, CDMO opened at $17.97, traded as high as $18.31 and as low as $17.68, and closed at $17.80. Trading volume was a total of 2.87M shares. On March 20, 2023, CDMO opened at $18.09, traded as high as $18.42 and as low as $17.81, and closed at $17.95. Trading volume was a total of 559.50K shares. On March 21, 2023, CDMO opened at $18.20, traded as high as $18.38 and as low as $17.95, and closed at $18.00. Trading volume was a total of 502.20K shares. On March 22, 2023, CDMO opened at $17.88, traded as high as $18.05 and as low as $17.33, and closed at $17.38. Trading volume was a total of 601.00K shares. On March 23, 2023, CDMO opened at $17.39, traded as high as $17.92 and as low as $17.18, and closed at $17.53. Trading volume was a total of 509.90K shares.

CDMO Historical Stock Prices By Date:

CDMO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Avid Bioservices shares, starting with a $10,000 purchase of CDMO, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 03/26/2013
End date: 03/23/2023
Start price/share: $1.33
End price/share: $17.53
Starting shares: 7,518.80
Ending shares: 9,423.17
Dividends reinvested/share: $0.66
Total return: 1,551.88%
Average Annual Total Return: 32.38%
Starting investment: $10,000.00
Ending investment: $165,154.35
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/26/2013
End date: 03/23/2023
Start price/share: $1.33
End price/share: $17.53
Dividends collected/share: $0.66
Total return: 1,267.37%
Average Annual Total Return: 29.90%
Starting investment: $10,000.00
Ending investment: $136,703.69
Years: 10.00
Date Close
03/17/2023$17.80
03/20/2023$17.95
03/21/2023$18.00
03/22/2023$17.38
03/23/2023$17.53
CDMO is categorized under the Healthcare sector; below are some other companies in the same sector:

CDNA Historical Stock Prices
CDTX Historical Stock Prices
CDXC Historical Stock Prices
CELC Historical Stock Prices
CELG Historical Stock Prices
CEMI Historical Stock Prices
CEMP Historical Stock Prices
CERC Historical Stock Prices
CERCU Historical Stock Prices
CERE Historical Stock Prices

Also explore: CDMO shares outstanding history

Email EnvelopeFree CDMO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CDMO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.